MRV Marvell Technology, Inc.
43.87CAD-0.36%Mkt Cap: 28.71B $P/E: 89.53Today
Industry Peers
Drug Manufacturers - GeneralKey Statistics
Company
Market Cap28.71B USD
Enterprise Value—
Revenue (TTM)—
Gross Profit3.04B USD
Net Income (TTM)1.94B USD
Revenue/Share—
Last Price43.87 CAD
Fiscal Year End—
MR Quarter—
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)89.53
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B1.50
EPS (TTM)—
EPS (Forward)—
52W Range
26.0064% of range53.75
52W High53.75 CAD
52W Low26.00 CAD
Profitability
Gross Margin51.02%
Oper. Margin—
EBITDA Margin—
Profit Margin32.58%
ROE18.66%
ROA11.98%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF1.27B USD
CapEx (TTM)261.15M USD
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.33
Current Ratio—
Quick Ratio—
Book Value/Sh29.28 CAD
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.24 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.876.93M
Float—
Insiders—
Institutions—
Technical
SMA 5036.81 (+19.2%)
SMA 20037.78 (+16.1%)
Beta—
S&P 52W Chg—
Avg Vol (30d)152.79K
Avg Vol (10d)119.27K
Technical Indicators
RSI (14)64.0
MACD1.8726
MACD Signal1.5506
MACD Hist.+0.3220
BB Upper45.94 CAD
BB Middle40.21 CAD
BB Lower34.49 CAD
BB Width28.47%
ATR (14)2.018 CAD
Vol Ratio (20d)0.94x